Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Sglt Inhibitors,High Purity Sglt Inhibitors,Sglt Inhibitors Drug
Conbott Pharmtech Co.,Ltd. Sglt Inhibitors,High Purity Sglt Inhibitors,Sglt Inhibitors Drug
Home > Products > Inhibitors > SGLT Inhibitors
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

SGLT Inhibitors

Product categories of SGLT Inhibitors, we are specialized manufacturers from China, Sglt Inhibitors, High Purity Sglt Inhibitors suppliers/factory, wholesale high-quality products of Sglt Inhibitors Drug R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
View: List Grid
SGLT2 Inhibitor Ipragliflozin (ASP1941) CAS 761423-87-4
SGLT2 Inhibitor Ipragliflozin (ASP1941) CAS 761423-87-4

Model No. : 761423-87-4

Ipragliflozin CAS No.761423-87-4,is a potent and selective inhibitor that used in the treatment of type 2 diabetes.We are excellent supplier of Ipragliflozin CAS 761423-87-4 and it is offered with high quality and attractive price. We are able to...

China Manufacturer of Sglt Inhibitors
Hot Sale Lpragliflozin L-Proline CAS 951382-34-6
Hot Sale Lpragliflozin L-Proline CAS 951382-34-6

Model No. : 951382-34-6

We are well-known in the market for offering premium quality Lpragliflozin L-Proline CAS 951382-34-6. Lpragliflozin L-Proline 951382-34-6 is white powder with molecular formula C21H21FO5S.C5H9NO2 and formula weight 519.58. Lpragliflozin L-Proline is...

High Quality High Purity Sglt Inhibitors China Supplier
UNII-M6N3GK48A4, Lpragliflozin L-Proline CAS 951382-34-6
UNII-M6N3GK48A4, Lpragliflozin L-Proline CAS 951382-34-6

Model No. : 951382-34-6

L-Proline compd. with (1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol (1:1) referred as Lpragliflozin L-Proline CAS 951382-34-6. The optimum quality Lpragliflozin L-Proline CAS NO 951382-34-6 we supplied to clients is...

Professional Manufacturer of Sglt Inhibitors Drug
Hot Sale Dapagliflozin, CAS 461432-26-8
Hot Sale Dapagliflozin, CAS 461432-26-8

Model No. : 461432-26-8

Backed by a team of professional, we offer a range of Dapagliflozin CAS 461432-26-8. Dapagliflozin 461432-26-8 appearance is white powder, which API is widely used to treating type2 diabetes. We adopt high quality ingredients and precise...

Expert Manufacturer of Sglt Inhibitors
Empagliflozin, BI-10773, CAS 864070-44-0
Empagliflozin, BI-10773, CAS 864070-44-0

Model No. : 864070-44-0

Backed by a professional team, we recommend a high quality Empagliflozin CAS 864070-44-0 to client with great enthusiasm. Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome...

China Supplier of High Purity Sglt Inhibitors

China SGLT Inhibitors Suppliers

Na + - glucose co-transporter (SGLT) is a type of protein gene family was found in the small intestine (SGLT-1) and renal proximal tubule (SGLT-1, SGLT-2) ,responsible for the absorption and re-absorption of glucose. in order to maintain stability and balance of blood sugar,In the kidney, the SGLT-2 protein again transport glomerular filtration of vast majority glucose into the blood, Sglt Inhibitors by blocking the transport mechanism of the protein, excreted glucose in the urine thereby reducing blood sugar, It creates good idea for the treatment of diabetes.
SGLT2 inhibitor is approved for use as monotherapy, which means that monotherapy of these drugs has been verified. Studies showed Canagliflozin as a single therapeutic agent for the disease through diet and exercise of type 2 diabetes patients which can not be controlled . Compared with other anti-diabetic drugs, SGLT-2 Inhibitors has the following advantages: (1) wider use scope, particularly suitable for blood glucose renal of diabetic patients; (2) unlikely to cause low blood sugar, can improve β-cell function and insulin resistance; (3) reducing the possibility retention of water sodium, reducing the risk caused by cardiovascular disease; (4) low side effects, especially to achieve energy balance, thus less reducing the patient physical.
Another important trend is SGLT-2 inhibitor drug development is composed with other drugs forms to improve the efficacy and reducing side effects. Such as Bristol-Myers Squibb and AstraZeneca jointly developed Dapagliflozin + metformin complex forms, the Johnson company developed a composite Canagliflozin + metformin dosage, Boehringer Ingelheim developed Empagliflozin + Linagliptin complex forms, Boehringer Ingelheim developed Empagliflozin + metformin complex formulations. SGLT2 inhibitors are evaluated when approved, the main concern is side effects of urogenital tract infection-related . Some researchers worry it will cause physical loss, low blood pressure and fracture, but studies have not found evidence of these complications. Overall SGLT inhibitor is still the hot spot in the field of diabetes research.

Conbottpharm could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Copyright © 2018 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?